Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils

Biology Open

Volumn 4, Issue 9, 2015, Pages 1206-1212

  Castellano, Laura M ^a   Hammond, Rebecca M ^a,b   Holmes, Veronica M ^c   Weissman, Drew ^c   Shorter, James ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SWARTHMORE COLLEGE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

EGCG; HIV infectivity; PAP85 120; SEM1; SEM2; SEVI

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; AMYLOID; EPIGALLOCATECHIN GALLATE; PROSTATE ACID PHOSPHATASE 248-286; PROSTATIC ACID PHOSPHATASE 85-120; SEMENOGELIN 1; SEMENOGELIN 2; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREACTIVITY; NONHUMAN; SPERM; VIRUS TRANSMISSION;

EID: 84982064332     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.010215     Document Type: Article

References (50)

1. Andrich, K. and Bieschke, J. (2015). The Effect of (-)-Epigallo-catechin-(3)-gallate on amyloidogenic proteins suggests a common mechanism. Adv. Exp. Med. Biol. 863, 139-161.
2. Arnold, F., Schnell, J., Zirafi, O., Sturzel, C., Meier, C., Weil, T., Standker, L., Forssmann, W.-G., Roan, N. R., Greene, W. C. et al. (2012). Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. J. Virol. 86, 1244-1249.
3. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K. and Wanker, E. E. (2010). EGCG remodels mature alphasynuclein and amyloid-beta fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. USA 107, 7710-7715.
4. Cabrera, C., Artacho, R. and Gimeñez, R. (2006). Beneficial effects of green tea-a review. J. Am. Coll. Nutr. 25, 79-99.
5. Cao, P. and Raleigh, D. P. (2012). Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. Biochemistry 51, 2670-2683.
6. Castellano, L. M. and Shorter, J. (2012). The surprising role of amyloid fibrils in HIV infection. Biology 1, 58-80.
7. Castellano, L. M., Bart, S. M., Holmes, V. M., Weissman, D. and Shorter, J. (2015). Repurposing Hsp104 to antagonize seminal amyloid and counter HIV infection. Chem. Biol.
8. Chandrashekaran, I. R., Adda, C. G., MacRaild, C. A., Anders, R. F. and Norton, R. S. (2011). EGCG disaggregates amyloid-like fibrils formed by Plasmodium falciparum merozoite surface protein 2. Arch. Biochem. Biophys. 513, 153-157.
9. Duennwald, M. L. and Shorter, J. (2010). Countering amyloid polymorphism and drug resistance with minimal drug cocktails. Prion 4, 244-251.
10. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A. and Wanker, E. E. (2008). EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558-566.
11. Fassina, G., Buffa, A., Benelli, R., Varnier, O. E., Noonan, D. M. and Albini, A. (2002). Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent. AIDS 16, 939-941.
12. Ferreira, N., Saraiva, M. J. and Almeida, M. R. (2011). Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Lett. 585, 2424-2430.
13. Finnegan, C. M., Rawat, S. S., Puri, A., Wang, J. M., Ruscetti, F. W. and Blumenthal, R. (2004). Ceramide, a target for antiretroviral therapy. Proc. Natl. Acad. Sci. USA 101, 15452-15457.
14. Fokkens, M., Schrader, T. and Kla?rner, F.-G. (2005). A molecular tweezer for lysine and arginine. J. Am. Chem. Soc. 127, 14415-14421.
15. Hartjen, P., Frerk, S., Hauber, I., Matzat, V., Thomssen, A., Holstermann, B., Hohenberg, H., Schulze, W., Schulze zur Wiesch, J. and van Lunzen, J. (2012). Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG. AIDS Res. Ther. 9, 2.
16. Hauber, I., Hohenberg, H., Holstermann, B., Hunstein, W. and Hauber, J. (2009). The main green tea polyphenol epigallocatechin-3-gallate counteracts semenmediated enhancement of HIV infection. Proc. Natl. Acad. Sci. USA 106, 9033-9038.
17. Hurshman, A. R., White, J. T., Powers, E. T. and Kelly, J. W. (2004). Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43, 7365-7381.
18. Jackrel, M. E., DeSantis, M. E., Martinez, B. A., Castellano, L. M., Stewart, R. M., Caldwell, K. A., Caldwell, G. A. and Shorter, J. (2014). Potentiated Hsp104 variants antagonize diverse proteotoxic misfolding events. Cell 156, 170-182.
19. Jiang, F., Chen, W., Yi, K., Wu, Z., Si, Y., Han, W. and Zhao, Y. (2010). The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors. Clin. Immunol. 137, 347-356.
20. Kawai, K., Tsuno, N. H., Kitayama, J., Okaji, Y., Yazawa, K., Asakage, M., Hori, N., Watanabe, T., Takahashi, K. and Nagawa, H. (2003). Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J. Allergy Clin. Immunol. 112, 951-957.
21. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W. and Glabe, C. G. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
22. Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L. et al. (2007). Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers. Mol. Neurodegener. 2, 18.
23. Khurana, S., Venkataraman, K., Hollingsworth, A., Piche, M. and Tai, T. C. (2013). Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients 5, 3779-3827.
24. Kim, K.-A., Yolamanova, M., Zirafi, O., Roan, N. R., Staendker, L., Forssmann, W.-G., Burgener, A., Dejucq-Rainsford, N., Hahn, B. H., Shaw, G. M. et al. (2010). Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 7, 55.
25. Lai, Z., Coloñ, W. and Kelly, J. W. (1996). The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35, 6470-6482.
26. Li, S., Hattori, T. and Kodama, E. N. (2011). Epigallocatechin gallate inhibits the HIV reverse transcription step. Antivir. Chem. Chemother. 21, 239-243.
27. Lump, E., Castellano, L. M., Meier, C., Seeliger, J., Erwin, N., Sperlich, B., Stu?rzel, C. M., Usmani, S., Hammond, R. M., von Einem, J. et al. (2015). A molecular tweezer antagonizes seminal amyloids and HIV infection. eLIfe 4, e05397.
28. Lundquist, F. (2008). Proteolytic enzymes in human semen. In Ciba Foundation Symposium - Mammalian Germ Cells (ed. G. E. W. Wolstenholme), pp. 71-81: John Wiley & Sons, Ltd., Chichester, UK.
29. Meng, F., Abedini, A., Plesner, A., Verchere, C. B. and Raleigh, D. P. (2010). The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 49, 8127-8133.
30. Mu?nch, J., Ru?cker, E., Sta?ndker, L., Adermann, K., Goffinet, C., Schindler, M., Wildum, S., Chinnadurai, R., Rajan, D., Specht, A. et al. (2007). Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 131, 1059-1071.
31. Nance, C. L. and Shearer, W. T. (2003). Is green tea good for HIV-1 infection? J. Allergy Clin. Immunol. 112, 851-853.
32. Nance, C. L., Siwak, E. B. and Shearer, W. T. (2009). Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy. J. Allergy Clin. Immunol. 123, 459-465.
33. Palhano, F. L., Lee, J., Grimster, N. P. and Kelly, J. W. (2013). Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J. Am. Chem. Soc. 135, 7503-7510.
34. Popovych, N., Brender, J. R., Soong, R., Vivekanandan, S., Hartman, K., Basrur, V., Macdonald, P. M. and Ramamoorthy, A. (2012). Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP (248-286). J. Phys. Chem. B 116, 3650-3658.
35. Roan, N. R., Mu?nch, J., Arhel, N., Mothes, W., Neidleman, J., Kobayashi, A., Smith-McCune, K., Kirchhoff, F. and Greene, W. C. (2009). The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J. Virol. 83, 73-80.
36. Roan, N. R., Mu?ller, J. A., Liu, H., Chu, S., Arnold, F., Stu?rzel, C. M., Walther, P., Dong, M., Witkowska, H. E., Kirchhoff, F. et al. (2011). Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe 10, 541-550.
37. Roan, N. R., Liu, H., Usmani, S. M., Neidleman, J., Muller, J. A., Avila-Herrera, A., Gawanbacht, A., Zirafi, O., Chu, S., Dong, M. et al. (2014). Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection. J. Virol. 88, 7221-7234.
38. Roberts, B. E. and Shorter, J. (2008). Escaping amyloid fate. Nat. Struct. Mol. Biol. 15, 544-546.
39. Roberts, B. E., Duennwald, M. L., Wang, H., Chung, C., Lopreiato, N. P., Sweeny, E. A., Knight, M. N. and Shorter, J. (2009). A synergistic small-molecule combination directly eradicates diverse prion strain structures. Nat. Chem. Biol. 5, 936-946.
40. Shorter, J. (2008). Hsp104: a weapon to combat diverse neurodegenerative disorders. Neurosignals 16, 63-74.
41. Shorter, J. (2010). Emergence and natural selection of drug-resistant prions. Mol. Biosyst. 6, 1115-1130.
42. Steinmann, J., Buer, J., Pietschmann, T. and Steinmann, E. (2013). Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br. J. Pharmacol. 168, 1059-1073.
43. UNAIDS (2011). World AIDS Day Report 2011. 1-48.
44. Usmani, S. M., Zirafi, O., Müller, J. A., Sandi-Monroy, N. L., Yadav, J. K., Meier, C., Weil, T., Roan, N. R., Greene, W. C., Walther, P. et al. (2014). Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen. Nat. Commun. 5, 3508.
45. Wang, H., Duennwald, M. L., Roberts, B. E., Rozeboom, L. M., Zhang, Y. L., Steele, A. D., Krishnan, R., Su, L. J., Griffin, D., Mukhopadhyay, S. et al. (2008). Direct and selective elimination of specific prions and amyloids by 4,5-dianilinophthalimide and analogs. Proc. Natl. Acad. Sci. USA 105, 7159-7164.
46. Westermark, G. T. and Westermark, P. (2008). Transthyretin and amyloid in the islets of Langerhans in type-2 diabetes. Exp. Diabetes Res. 2008, 429274.
47. Woods, L. A., Platt, G. W., Hellewell, A. L., Hewitt, E. W., Homans, S. W., Ashcroft, A. E. and Radford, S. E. (2011). Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. Nat. Chem. Biol. 7, 730-739.
48. Yamaguchi, K., Honda, M., Ikigai, H., Hara, Y. and Shimamura, T. (2002). Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antiviral Res. 53, 19-34.
49. Yang, C. S., Maliakal, P. and Meng, X. (2002). Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42, 25-54.
50. Zhang, H.-S., Wu, T.-C., Sang, W.-W. and Ruan, Z. (2012). EGCG inhibits Tatinduced LTR transactivation: role of Nrf2, AKT, AMPK signaling pathway. Life Sci. 90, 747-754.